Following BEST-CLI and BASIL-2
Chronic limb-threatening ischemia (CLTI) is the most severe manifestation of peripheral arterial disease (PAD) including ischemic pain, ulcerations, and/or gangrene repre…
CLIGS Multidisciplinary Roundtable Discussion on BEST-CLI
The long-awaited results of the BEST-CLI trial were recently published in the New England Journal of Medicine and presented at the 2022 American Heart Association Scientifi…
The BEST-CLI Trial: Time for Pause or Action?
The initial results of the long-awaited BEST-CLI (Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia) trial were recently published in the New England Jo…
Totally Percutaneous Access Versus Surgical Cutdown In TAVI
From the 1st Department of Cardiology, Medical School of Athens University, Hippokration Hospital, Athens, Greece; and *Henry Dunant Hospital, Athens, Greece Disclosure: The a…
MicroStent — a Novel Device Designed for Treatment of CLTI BTK
From Policlinico Abano Terme Padova Italy, Onze Lieve Vrouwziekenhuis (OLV) Aalst Belgium, Karolinen Hospital Arnsberg Germany, Ziekenhuis Oost-Limburg (ZOL) Genk Belgium, St…
Patterns of Failure in Deep Venous Arterialization and Implications for Management
The primary objective of this study was to describe a novel classification system to characterize patterns of failure in deep venous arterialization (DVA) and suggest intervent…
Preoperative C-Reactive Protein Levels Predict Readmission Following Elective Vascular Surgery
C-reactive protein (CRP) levels may be reduced with long-term administration of ubiquinone (CoQ10) in patients with chronic ischemic heart disease, but the impact of a sh…
The Impact of the SARS-CoV-2 Pandemic on the Management of Chronic Limb-Threatening Ischemia and Wound Care
Authors: Vickie R. Driver DPM, MS, FACFAS, FAAWC, Kara S. Couch MS, CRNP, CWCN-AP, FAAWC, Kristen A. Eckert MPhil, Gary Gibbons MD, Lorena Henderson APRN, MSN, FNP-C, John Lantis…